OxTalks is Changing
OxTalks will soon be transitioning to Oxford Events (full details are available on the Staff Gateway). A two-week publishing freeze is expected in early Hilary to allow all events to be migrated to the new platform. During this period, you will not be able to submit or edit events on OxTalks. The exact freeze dates will be confirmed as soon as possible.
If you have any questions, please contact halo@digital.ox.ac.uk
Restoring the balance with Regulatory T Cell Therapies
Quell Therapeutics is a London based, private biopharmaceutical company. Their vision is to be the leading engineered cell therapy company, bringing transformational and valued therapies addressing a range of autoimmune and inflammatory diseases, as well as preventing rejection in organ transplantation.
Date:
18 January 2024, 12:00
Venue:
Seminar room
Speaker:
Luke Devey (Chief Medical Officer)
Organising department:
Department of Paediatrics
Organiser:
Sheena Lee (MSD Business Partnerships Office)
Booking required?:
Not required
Booking url:
https://forms.office.com/e/suZ1J5CiU1
Cost:
None
Audience:
Members of the University only
Editor:
Laura Borg
